Background. Human babesiosis is an emerging health problem in China. Methods. Babesia were identified in ticks, sheep, and humans in northeastern China using polymerase chain reaction (PCR) followed by genetic sequencing. We enrolled residents who experienced a viral-like illness after recent tick bite or were healthy residents. We defined a case using the definition for babesiosis developed by the US Centers for Disease Control and Prevention.
Human babesiosis is a worldwide emerging zoonosis caused by intraerythrocytic protozoa of the genus Babesia, which are usually transmitted by ticks but also through blood transfusion and perinatally [1] [2] [3] . More than 100 Babesia species infect a wide array of wild and domestic animals and have had a significant economic impact in livestock, but only a few species have been documented to infect humans [1] . These include Babesia microti, Babesia duncani, Babesia divergens, Babesia venatorum, and Babesia sp. KO1 [1] . Some Babesia that infect humans have a distinct genetic profile but are closely related to another recognized human Babesia pathogen. For example, B. divergens has long been recognized as a human pathogen in Europe, but more recently a closely related B. divergens-like pathogen has been found to cause human disease in the United Sates [4] [5] [6] [7] .
Babesiosis is an emerging health problem in China. Only 14 human babesiosis cases were reported before 2010 in mainland China [8, 9] . Over the past few years, many more cases have been diagnosed, including 49 infected with B. venatorum [10, 11] , 11 with B. microti [12, 13] , 2 with B. divergens [14] , 1 with Babesia sp. XXB/HangZhou [15] , and 1 with a species that remains uncharacterized [16] . To better understand its endemic status, we investigated Babesia infection in questing ticks from northeastern China where tick bites are commonly reported. We discovered a Babesia crassa-like agent in ticks through amplification and sequence analyses of the nearly full-length 18S ribosomal RNA gene, β-tubulin gene, and internal transcribed spacer 2 (ITS2). Babesia crassa has been described in sheep in Iran and Turkey [17, 18] . We then searched for human infection with this agent. Here, we describe the identification of this Babesia pathogen in humans and report its genetic, clinical, and epidemiological characteristics.
METHODS

Survey and Identification of Babesia in Ticks and Sheep
From May 2014 through July 2014, we collected questing ticks by flagging over vegetation at 2 sites near Mudanjiang City, Heilongjiang Province, northeastern China (Figure 1 ). The 2 collection sites are forested highlands with elevation of 410 m M A J O R A R T I C L E and 550 m above sea level (Figure 1 ). The species and developmental stage of the ticks were identified by an entomologist. All ticks were stored at −20℃ until further analysis.
We extracted DNA from ticks using a tissue DNA extraction kit (Tiangen Biotechnique, Beijing, China) according to the manufacturer's instructions. To detect Babesia infection in ticks, we conducted polymerase chain reaction (PCR) that targeted a fragment of the 18SrRNA gene of Babesia (408 base pairs [bp] ) and sequenced all positive amplicons for confirmation (primers PIRO-A/PIRO-B in Supplementary Table 1 ) [19] . The PIRO-A/PIRO-B primer sets can amplify B. microti, B. divergens, "B. venatorum, " and other Babesia species (Supplementary Figure 1) . For identification, all positive samples were retested to amplify the nearly full-length 18S rRNA gene [20] , a partial segment of the β-tubulin gene [21] , and the ITS2 [22] (Supplementary Table 1 ).The sequences obtained were compared with sequences deposited in GenBank using the Basic Local Alignment Search Tool. Phylogenetic analyses were performed using the maximum likelihood method in Molecular Evolutionary Genetics Analysis, version 6.0 (www.megasoftware. net). Because sheep may serve as a reservoir host, blood samples were collected from sheep and analyzed using the same PCR screening procedure and sequencing as for ticks (Figure 1 ).
Survey for Babesia in Humans
From May 2015 through July 2016, we recruited participants who experienced a viral-like illness after a tick bite in the previous 2 months and saw a physician at Mudanjiang Forestry Central Hospital, Heilongjiang Province, northeastern China ( Figure 1 ). This is the same region where various tick-borne diseases have been reported and where we screened ticks for Babesia [8, 10, [23] [24] [25] [26] [27] . Blood samples were collected for analysis of tick-borne infections on the day the participant saw a doctor. Each participant was asked to complete a standardized questionnaire that included demographic information, medical history, tick bite history, and environmental exposure. Information about clinical manifestations, underlying conditions, laboratory tests, treatment, and outcomes were retrieved from medical records by 2 of the authors for cross-corroboration. We also collected blood samples from some Babesia-infected patients 9 months after initial diagnosis to investigate the possibility of persistent infection. The same questionnaire was administered again to collect relevant data.
We also recruited healthy permanent residents of the same area who participated in a routine well care examination at the Mudanjiang Forestry Central Hospital and the International Travel Healthcare Center. These residents were asked to complete the same questionnaire and to provide a blood sample for Babesia testing.
All participants were asked to provide oral or written informed consent. The Academy of Military Medical Sciences Review Board (Beijing, China) reviewed and approved the study protocol .
Molecular Detection of Human Infections
We extracted DNA from the blood of each participant using the QIAamp DNA blood mini kit (Qiagen, Germantown, Maryland) according to the manufacturer's instructions. Based on the analysis of the nearly full-length 18S rRNA gene of the Babesia identified in ticks, a set of specific nested PCR primers (18SF-OUT/18SR-OUT and18SF-IN/18SR-IN) were designed to screen human infections (Supplementary Table 1 , Supplementary Figure 2 ). All positive amplicons were sequenced for confirmation of infection and discrimination from other Babesia species (Supplementary Figure 3 ).
All samples were tested for amplifiable DNA using PCR assays for "B. venatorum" [10] , spotted fever group rickettsiae [23] , pathogens in the Anaplasmataceae family [25] , and Borrelia burgdorferi sensu lato [27] . All the amplicons in the study were bidirectionally sequenced for resolving ambiguities in a sequence from 1 of the 2 strands.
Blood Smear Examination
Giemsa-stained peripheral thin blood smears of PCR-positive patients were examined using a light microscope (BX43, Olympus, Tokyo, Japan) for the presence of intraerythrocytic parasites. At least 300 microscopic fields were viewed for each smear using an oil immersion microscope to avoid missing low parasitemia.
Case Definition
We used the babesiosis case definition for the purposes of surveillance that was developed by the US Centers for Disease Control and Prevention (CDC) [2] . Briefly, confirmed cases had 1 or more objective (fever, anemia, or thrombocytopenia) or subjective (chills, sweating, headache, myalgia, or arthralgia) clinical criteria and 1 or both of the following laboratory confirmatory criteria: detection of Babesia sequences in a whole blood specimen by PCR or identification of intraerythrocytic Babesia organisms by light microscopy in a Giemsa-stained blood smear. The suspected cases had confirmatory laboratory evidence but did not meet any objective or subjective clinical evidence criteria.
Statistical Analyses
Continuous variables were summarized as median and range, and categorical variables were summarized as frequencies and proportions with 95% confidence interval (CI). A 2-sided P value < .05 was considered significant. All analyses were performed using SPSS software (version 18.0).
RESULTS
Babesia in Ticks and Sheep
A total of 1732 adult ticks were collected and tested for Babesia infection, including 1296 Ixodes persulcatus, 184 Dermacentor sylvarum, and 252 Haemaphysalis concinna. Babesia DNA was amplified from 15 ticks for an infection rate of 0.9% (95% CI, 0.5%-1.4%; Table 1 ). The sequence analysis revealed that the nucleotide sequences of the partial 18S rRNA gene amplified from 3 I. persulcatus and 3 D. silvarum samples were identical to each other and to the corresponding fragment of B. venatorum (KM244044). The other 9 (8 in I. persulcatus and 1 in H. concinna) positive samples had 99.5%-100% identity, among which 4 were identical with each other and the other 5 had 1-or 2-bp differences. A BLAST search in GenBank revealed that the closest matched species was B. crassa (AY260176), but with 14-bp differences.
We successfully obtained a nearly full-length 18S rRNA gene sequence from 5 of 9 tick samples that contained the B. crassa-like species, including 4 in I. persulcatus and 1 in H. concinna. The sequences obtained from 2 I. persulcatus were identical (KU204783) and differed by 4 bp and 3 bp from those of the other 2 I. persulcatus (KU204785, KU204786). The Babesia sequence in H. concinna (KU204781) had 4-bp differences from that in I. persulcatus (KU204783). The phylogenetic tree based on the near full-length 18S rRNA gene sequences (1530 bp) showed that the Babesia species identified in this study were clustered in the same clade with those that we previously detected in 2012 from I. persulcatus (JX542615) and H. concinna (JQ993418) in China (Figure 2A) . The closest species match was B. crassa that was isolated from sheep in Iran (AY260176) and Turkey (AY260177). They had 96.7%-97.7% similarities in sequence and constituted a clade in the Figure 2B ) indicated that the sequences detected in this study were similar to some unnamed Babesia strains that were found in ticks near our survey sites [28, 29] .
In order to further classify the agent, we carried out additional amplification of the β-tubulin gene (882 bp) and the ITS2 (373 bp) from 2 I. persulcatus. The nucleotide sequences from these ticks were identical and were submitted to GenBank with accession numbers KX827593 and KU377435, respectively. The Figure 2C and 2D) . Unfortunately, no β-tubulin gene and ITS2 sequences from B. crassa were available for the comparison.
Blood samples were collected from 461 sheep and analyzed using the same PCR screening procedure and sequencing as for ticks. Nearly full-length 18S rRNA gene sequences were obtained from 5 (1.1%) sheep. These sequences were identical to each other (KX684200) and to the sequence from the I. persulcatus tick (KU204786; Figure 2A) .
Detection of B. crassa-Like Species in Humans
Of the 1125 participants with a recent tick bite who enrolled in our study from 2015 to 2016, 58 (5.0%) had amplifiable B. crassa-like DNA in their blood based on species-specific PCR and sequencing. The genetic sequences (469 bp) obtained from the PCR-positive patients were identical to each other and to the sequence from I. persulcatus ticks (KU204783). Peripheral blood smears were available from 54 of the 58 cases, and Babesia parasites were detected in 11 patients with parasitemia counts from 1% to 2%. Ring forms were most commonly seen followed by amoeboid forms (Figure 3 ), while tetrads were not observed. The size of parasites (the diameter of ring forms or the length of the amoeboid form) was usually smaller than 3 μm. Of the 58 PCR-positive cases, 31 met the criteria for a confirmed case [2] . The other 27 cases were classified as suspected cases because although they had molecular or blood smear evidence of babesiosis, they had no clinical evidence of babesiosis, only nonspecific signs such as lymphadenopathy or local tick-bite inflammation (Table 2) .
A nearly full-length 18S rRNA gene was amplified from 15 blood samples (including 10 of 31 confirmed and 5 of 27 suspected cases). In sequence comparison, 14 sequences were identical to each other (KX590750) and to the sequence from the I. persulcatus (KU204783), while another sequence from a confirmed case (KX590751) showed a phylogenetic distance of 12 bp (Figure 2A ).
Epidemiological and Associated Clinical Characteristics of Study Participants Infected With B. crassa-Like Species
The median age of all 58 cases was 51 years (range, 4-72 years), and 39 (67%) were female. None of 58 cases had received a blood transfusion within the previous 2 years. All cases were previously healthy except for 1 suspected case with a history of ovarian tumor. None had ever undergone a splenectomy. Most cases (79%, 46/58) occurred in May. The most common occupations of the cases were farmers (61%) and forestry workers (24%). All cases reported a recent tick bite located on the scalp, ears, or neck or, less commonly, on the trunk or extremities.
Headache (74%), nausea or vomiting (52%), and fever (48%) were the most common clinical manifestations in confirmed cases (Table 2 ). An elevated white blood cell count was observed in 4 patients. Hepatic abnormalities occurred more often in confirmed cases than in suspected cases ( Table 2) .
Treatment data were available from 30 patients. Fifteen were initially treated with benzylpenicillin, 4 with cephalosporin, 2 with roxithromycin, and 8 with doxycycline (including 2 with doxycycline and benzylpenicillin). Three patients were given clindamycin alone. None received standard anti-babesial therapy with clindamycin and quinine or atovaquone and azithromycin. Symptoms resolved in most patients, and none died. About 9 months after initial diagnosis, 10 cases (3 confirmed and 7 suspected) were evaluated for possible sequelae and persistent infection. Six of the 10 cases (2 confirmed and 4 suspected) remained positive as determined by specific PCR and sequencing.
Coinfections with spotted fever group rickettsiae were found in 4 confirmed and 2 suspected cases. Further sequence analyses revealed that 3 confirmed cases were coinfected with Rickettsia raoultii and 1 with Candidatus R. tarasevichiae (Supplementary Table 2 ). Half of the coinfected cases (3/6) were hospitalized for severe illness. In addition, 7 cases with "B. venatorum" infection were identified but were not coinfected with B. crassa-like agent.
A total of 160 local residents who were seen for routine well care examination were tested for B. crassa-like infection using species-specific PCR and sequencing, and 12 (7.5%) were positive (Supplementary Table 3 ). Nearly full-length sequences of Babesia 18S rRNA gene were obtained in 6 of the 12 positive participants, and they were identical (KY052789) to each other and had 9-bp differences from the tick sequence (KU204783; Figure 2A ).
DISCUSSION
We identified a B. crassa-like protozoan that causes human infection. Confirmed or suspected cases met the criteria for case definition developed by the CDC [2] . In addition, asymptomatic infections were found among the people living in the same area. This Babesia pathogen is phylogenetically related to B. crassa, a large Babesia originally reported in sheep from Iran and Turkey [17, 18] . The parasites observed in the blood smears of patients in this study usually appeared as ring forms <3 μm (Figure 3) . Babesia crassa in sheep red blood cells generally are characterized by the occurrence of 4 organisms per red cell, with an average length of approximately 2.2 μm [18] . We provisionally named it "B. crassa-like agent. "
The patients we identified as infected with the B. crassa-like protozoa appear to have mild to moderate clinical manifestations. Headache (74%), nausea or vomiting (52%), fever (48%), and elevated total bilirubin (42%) were the most common clinical and laboratory manifestations, while those in "B. venatorum" cases were 41%, 16%, 66%, and 29%, respectively [10] . In our study, 27 cases were found to have amplifiable B. crassa-like DNA in their blood but lacked babesiosis-specific clinical signs or symptoms required for designation as confirmed cases. One reason for the absence of symptoms might be a lower virulence of this Babesia species, as suggested by low parasitemia levels detected on blood smears in these patients. All cases (with the possible exception of 1 patient) were immunocompetent, and such patients are less likely to develop severe babesiosis. We identified asymptomatic B. crassa-like infections in 7.5% of healthy residents living in the same area. The higher prevalence of B. crassa-like infection in the residents might be due to their repeated and intense exposure to the pathogen, as they usually work in the tick-affected forest (Supplemental Table 3 ). We found that babesial DNA was detectable for at least 9 months in 6 of 10 B. crassa-like cases who were not given anti-babesial therapy. Chronic asymptomatic infection occurs with B. microti and may persist for more than 2 years [3, 30] . Relapse of symptoms rarely occurs in people who are otherwise healthy, even in the absence of specific anti-babesial therapy [3, 30] . In contrast, immunocompromised people infected with B. microti are at risk of severe and persistent relapsing illness [31] . In China, 1 immunocompetent patient was reported to be infected with "Babesia sp. XXB/HangZhou" for 10 years [15] . Asymptomatic infection with B. crassa-like parasites would pose a public health threat if this infection can be transmitted through blood transfusion and/or organ donation. Blood and organ recipients usually are immunocompromised and are at significant risk of severe babesiosis [1, 3] .
Human babesiosis caused by B. microti typically resolves 1-2 weeks after administration of a single course of atovaquone and azithromycin or clindamycin and quinine. For asymptomatic carriers, treatment should be considered if the infection persists for longer than 3 months, although no controlled trials have examined this recommendation [1] . The standard diagnostic testing and treatment of babesiosis is seldom used in most Chinese hospitals, as we previously reported in our "B. venatorum" case series [10] .
The life cycle and vector competence of the B. crassa-like agent deserves further investigation. Babesia crassa-like agents have been reported in H. concinna (3.0%) and H. japonica (1.5%) ticks in the Russian Far-East region [28, 29] . In this study, the B. crassa-like agent was detected in 0.6% I. persulcatus and 0.4% H. concinna. A previous survey carried out in the same province detected the B. crassa-like parasite in 0.5% H. concinna and 0.1% I. persulcatus [29] .
There are a few limitations of our study. We were only able to carry out a follow-up survey 9 months after the first diagnosis, so the exact duration of persistent infection or the possibility of relapse of this disease is uncertain. Second, we used molecular methods to diagnose coinfection; however, seroconversion or a 4-fold titer increase of paired serum samples would have provided better evidence of coinfection. In addition, although we performed "B. venatorum"-specific blood PCR on samples from B. crassalike patients and found no evidence of coinfection with these 2 Babesia species, further surveillance should be performed in this region to compare the clinical differences of those 2 pathogens
In conclusion, we discovered that a B. crassa-like pathogen infects humans in northeastern China. Human infection is associated with mild to moderate symptoms in immunocompetent persons. Persistent parasitemia may occur in either untreated symptomatic patients or those with asymptomatic infection, raising the possibility of blood and organ donor transmission. Additional studies will need to be carried out to determine whether this pathogen occurs in other regions where Ixodid ticks are found.
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